Department of Ophthalmology, the Second Hospital of Jilin University, 218#Ziqiang Street, Nanguan District, Changchun 130041, PR China.
Tumor and Hematology, the Second Hospital of Jilin University, 218#Ziqiang Street, Nanguan District, Changchun 130041, PR China.
Biomed Pharmacother. 2019 Sep;117:109153. doi: 10.1016/j.biopha.2019.109153. Epub 2019 Jun 21.
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief and the authors. Panels from Figure 2C appear similar to panels from Figure 2C of the article that Xiaoxia Liu, Yiyang Li, Jihong Wen, Tingting Qi and Yanli Wang have published in Biomedicine & Pharmacotherapy 125 (2020) 109882 https://doi.org/10.1016/j.biopha.2020.109882, Figure 2C of the article that Minghe Li, Jun Ning, Zhihong Li, Qianyi Fei, Cong Zhao, Yue Ge and Lei Wang have published in Biomedicine & Pharmacotherapy 118 (2019) 109259 https://doi.org/10.1016/j.biopha.2019.109259 and Figures 3C, 7D and 8B of the article that Dongmei Han, Jianfeng Wang and Guanghui Cheng have published in Oncotarget 9 (2018) 2395-2409 https://doi.org/10.18632/oncotarget.23416. Although this article was published earlier than most of the other articles, the Editor decided to retract this article given concerns about the reliability of the data.
请参阅爱思唯尔关于文章撤回的政策(https://www.elsevier.com/about/our-business/policies/article-withdrawal)。应主编和作者的要求,撤回了本文。图 2C 的面板与刘晓霞、李义阳、温继宏、齐亭亭和王艳莉在《生物医学与药理学》125 期(2020 年)109882 上发表的文章[10.1016/j.biopha.2020.109882],李明鹤、宁军、李智宏、费乾义、赵聪、葛越和雷王在《生物医学与药理学》118 期(2019 年)109259 上发表的文章[10.1016/j.biopha.2019.109259],以及韩冬梅、王剑峰和程光辉在《肿瘤靶向》9 期(2018 年)2395-2409 上发表的文章[10.18632/oncotarget.23416]的图 3C、7D 和 8B 相似。尽管这篇文章比其他大多数文章发表得更早,但由于对数据可靠性的担忧,编辑决定撤回这篇文章。
请注意,以上译文可能存在一些错误或不流畅的地方,如果你需要更准确、自然的译文,请提供更多的上下文和信息。